CNPR Healthcare Industry Knowledge & Drug Approval Process 5 — Questions and Answers
Question 1: What is the primary function of the FDA's MedWatch program?
- To approve new drug applications from pharmaceutical manufacturers
- To monitor and collect voluntary adverse event and safety reports from healthcare professionals and consumers (Correct answer)
- To set reimbursement rates for prescription drugs under Medicare
- To inspect pharmaceutical manufacturing facilities for GMP compliance
Correct answer: To monitor and collect voluntary adverse event and safety reports from healthcare professionals and consumers
MedWatch is the FDA's safety information and adverse event reporting program, allowing voluntary reporting by clinicians and mandatory reporting by manufacturers.
Question 2: In pharmaceutical marketing, what does 'share of voice' measure?
- The percentage of patients who receive a drug sample during a physician visit
- A company's promotional spending or sales force activity relative to competitors in the same therapeutic category (Correct answer)
- The number of times a drug's brand name is mentioned in clinical journals
- A physician's willingness to discuss a drug with a sales representative
Correct answer: A company's promotional spending or sales force activity relative to competitors in the same therapeutic category
Share of voice quantifies how much of the total promotional effort in a market a company controls compared to its competitors, often correlating with market share.
Question 3: Which of the following best describes a 'prior authorization' (PA) requirement in pharmacy benefits?
- A prescriber must obtain approval from the FDA before writing a prescription for a controlled substance
- A health plan requires prescribers to obtain approval before covering a specific medication, often by demonstrating medical necessity (Correct answer)
- A pharmacist must confirm patient identity before dispensing any Schedule III drug
- A pharmaceutical rep must schedule an appointment before visiting a hospital account
Correct answer: A health plan requires prescribers to obtain approval before covering a specific medication, often by demonstrating medical necessity
Prior authorization is a managed care cost-control tool requiring prescribers to justify medical necessity before the plan will cover certain high-cost or specialized drugs.
Question 4: The Hatch-Waxman Act of 1984 achieved which two primary goals for the pharmaceutical industry?
- It established the FDA and created the NDA process
- It expedited generic drug approval via ANDAs and allowed brand manufacturers to extend patent terms lost during development (Correct answer)
- It created Medicare Part D and regulated direct-to-consumer advertising
- It mandated pharmacovigilance reporting and established the MedWatch system
Correct answer: It expedited generic drug approval via ANDAs and allowed brand manufacturers to extend patent terms lost during development
Hatch-Waxman simultaneously created the ANDA pathway for faster generic entry and granted brand companies patent term restoration to compensate for regulatory review time.
Question 5: A pharmaceutical company launches a Risk Evaluation and Mitigation Strategy (REMS) for a drug. What does this indicate?
- The drug has completed Phase III trials and received standard FDA approval
- The FDA determined the drug's benefits outweigh its risks only if specific safety measures are in place to manage serious risks (Correct answer)
- The drug is being approved solely for over-the-counter sale
- The company voluntarily recalled the drug pending further investigation
Correct answer: The FDA determined the drug's benefits outweigh its risks only if specific safety measures are in place to manage serious risks
REMS programs are required by FDA when a drug poses serious risks that can be managed only through restricted distribution or required safety protocols, not through labeling alone.
Question 6: Which of the following statements about Continuing Medical Education (CME) is most consistent with PhRMA guidelines?
- Pharmaceutical companies may directly control the content of CME programs they fund
- Commercially supported CME must be independent of the funding company's promotional interests (Correct answer)
- Reps may co-present at CME events alongside physicians to ensure product accuracy
- CME funding from pharma companies is prohibited under federal law
Correct answer: Commercially supported CME must be independent of the funding company's promotional interests
PhRMA guidelines and ACCME standards require that commercially supported CME be free from promotional bias and controlled independently by the accredited provider.
Question 7: A drug's package insert (PI) is also referred to as the 'label.' Who is the primary intended audience for this document according to FDA regulations?
- Patients and caregivers who purchase the drug at retail pharmacies
- Healthcare professionals, as the PI contains full prescribing information for clinical decision-making (Correct answer)
- FDA inspectors conducting manufacturing audits
- Health insurance actuaries calculating plan formulary costs
Correct answer: Healthcare professionals, as the PI contains full prescribing information for clinical decision-making
The FDA-approved prescribing information (package insert) is directed at licensed healthcare professionals and contains the complete clinical data, dosing, warnings, and contraindications.
CNPR Healthcare Industry Knowledge & Drug Approval Process 5
What is the primary function of the FDA's MedWatch program?